Advertisement
Asia
Subscribe to Asia

The Lead

ImmunoGen Lands Licensing Deal with Takeda

March 23, 2015 4:08 pm | by The Associated Press | News | Comments

Takeda will use ImmunoGen's technology to develop cancer treatments. ImmunoGen will get $20 million upfront and is eligible for milestone payments potentially totaling up to $210 million, plus royalties on sales.

Report: Japan's Pharmaceutical Market to See 'Tepid' Growth

March 2, 2015 8:10 am | by Andy Szal, Digital Reporter | News | Comments

A recent report from research firm GlobalData predicted Japan will see a "tepid" recovery in its...

Takeda Expands Pharma Operations in Singapore

February 25, 2015 8:14 am | News | Comments

Takeda Pharmaceutical Co., Japan's largest drug company, has expanded its Singapore operations...

Report: Vitamin Supplement Market Expected to Increase by 60 Percent by 2020

February 24, 2015 3:19 pm | by Andrew Szal, Editor, Pharmaceutical Processing | News | Comments

The analysis by New York-based Persistence Market Research predicted Vitamin D supplements would...

View Sample

FREE Email Newsletter

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi and Harvoni in India

February 23, 2015 8:13 am | News | Comments

Mylan announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi and Harvoni for the treatment of chronic hepatitis C, in India.

Indian Health Authorities Say 700 Have Died in Flu Outbreak

February 20, 2015 8:36 am | News | Comments

Health authorities were working to ensure remote hospitals in northern and western India had adequate medical supplies for a flu outbreak that has claimed more than 700 lives in 10 weeks.

China’s Colorectal Cancer Treatment Market Value to Exceed $1 Billion by 2023, says GlobalData

February 18, 2015 8:57 am | News | Comments

The Chinese treatment market for colorectal cancer (CRC) will expand almost fourfold in value from an estimated $259 million in 2013 to $1.05 billion by 2023, at an impressive Compound Annual Growth Rate (CAGR) of 15.1%, according to research and consulting firm GlobalData.

Advertisement

Merck Takes Full Promotional Responsibility for Erbitux in Japan

February 13, 2015 8:43 am | News | Comments

Merck has announced that the company and Bristol-Myers Squibb have agreed to transfer full responsibility for the promotion of Erbitux® (cetuximab) to Merck in Japan as of May 1, 2015

U.S. Challenges Chinese Export Program

February 11, 2015 11:56 am | by Andrew Szal, Editor, Pharmaceutical Processing | News | Comments

The United States has accused the Chinese government of providing prohibited subsidies on a wide range of the country's exports, providing an unfair advantage in the marketplace and hindering American businesses.

Report: Single-Use Bioreactors Market to Grow to $471M by 2019

January 28, 2015 8:02 am | News | Comments

The single use bioreactors (SUBs) market is expected to grow at a double digit CAGR of 18.4% to reach $470.9 million by 2019 from $202.5 million in 2014. Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.

EMA Recommends Suspending GVK Biosciences Medicines over Flawed Studies

January 23, 2015 8:06 am | News | Comments

A number of medicines for which authorization in the European Union (EU) was primarily based on clinical studies conducted at GVK Biosciences in Hyderabad, India should be suspended, says the European Medicines Agency (EMA).     

Catalent Biologics and MGC Pharma Announce Partnership for Biomanufacturing in Asia

January 19, 2015 12:29 pm | News | Comments

Catalent Pharma Solutions and Mitsubishi Gas Chemical Company, Inc. (MGC), have entered into a partnership agreement to co-promote Catalent’s proprietary GPEx® technology in the Asian market.          

Advertisement

Roche, Meiji and Fedora to Collaborate on New Antibiotic to Fight Increasing Bacterial Resistance

January 13, 2015 11:26 am | News | Comments

Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the development and commercialization of OP0595, a beta-lactamase inhibitor in phase I clinical development. Under the agreement, Roche obtains worldwide rights from both companies for development and commercialization with the exception of Japan, where Meiji will retain sole commercialization rights.

Health Canada Quarantines Products From Two Indian Companies

December 24, 2014 11:00 am | News | Comments

This action comes in light of recent information from a trusted regulatory partner that raises concerns about the reliability of the laboratory data generated at these sites. Health Canada is taking this action as an interim precautionary measure to help mitigate any potential risk.

PPD and SNBL to Provide Clinical Development Services in Japan

December 24, 2014 8:25 am | News | Comments

Pharmaceutical Product Development and Shin Nippon Biomedical Labs have formed a joint venture that will provide a full range of clinical development services in Japan, including Phase I-IV clinical trial monitoring, project management, site intelligence and activation, biostatistics, data management, medical writing, pharmacovigilance, regulatory and FSP services.

Sartorius Selling Industrial Technologies Division to Minebea Co.

December 22, 2014 8:36 am | News | Comments

Sartorius, an international laboratory and pharmaceutical equipment provider, is selling its Industrial Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea) and their partner, the Development Bank of Japan Inc.   

Charges Dropped Against Two Former Lilly Scientists

December 8, 2014 8:34 am | News | Comments

Two former Eli Lilly and Co. employees who were accused of sending trade secrets worth more than $55 million to a competing Chinese drug company will no longer face charges, the U.S. attorney's office announced Friday.      

Advertisement

GlobalData: Age-Related Macular Degeneration Treatment Market Value to Exceed $10B by 2023

December 4, 2014 9:51 am | News | Comments

The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and Japan) will almost double in value from $5.1 billion in 2013 to $10.1 billion by 2023, according to research and consulting firm GlobalData.

Otsuka to Buy Avanir for $3.5B

December 2, 2014 7:08 am | by By The Associated Press | News | Comments

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal that expands the Japanese drugmaker's portfolio of neurologic disease treatments. Avanir shareholders will receive $17 per share, according to the agreement announced Tuesday.

Vetter Opens Singapore Office to Support Growing Asian Healthcare Market

November 20, 2014 8:42 am | News | Comments

Vetter has announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government agencies and a number of executives of pharmaceutical/biotech companies with a presence in the Asian region, as well as Vetter executives.

China Convicts Pharmaceutical Web Marketer in Anti-Rumor Campaign

November 18, 2014 8:06 am | News | Comments

A Beijing court has convicted an Internet marketer of illegal business practices and sentenced him to four years in prison for posting false information and deleting posts critical of his clients, in a case that state media have used to praise a government crackdown on online expression.

Drug Maker Arrested in India Sterilization Deaths

November 17, 2014 8:25 am | by MUNEEZA NAQVI, Associated Press | News | Comments

Press Trust of India reported that Ramesh Mahawar of Mahawar Pharma Pvt Ltd and his son were arrested and charged with fraud. Police Superintendent O.P. Pal told PTI that the men were arrested on the complaint of food and drug administration officials.

India Doctor Arrested, Denies Role in Women Deaths, Blames Medication

November 13, 2014 10:07 am | by MUNEEZA NAQVI, Associated Press | News | Comments

The doctor who conducted sterilization procedures after which 13 women died in central India was arrested, but insisted he didn't do anything wrong — even though he said he used to perform up to 10 times more surgeries a day than allowed.    

Doctors Rush to India after Sterilization Deaths

November 12, 2014 8:30 am | by KATY DAIGLE, Associated Press | News | Comments

A team of doctors rushed to central India on Wednesday after at least 12 women died and dozens of others fell ill following sterilization surgeries in a free, nationwide program aimed at limiting births in the world's second-most populous nation, officials said.

China Factory Whirs Overtime to Make Ebola Suits

November 6, 2014 10:56 am | by ZHANG WEIQUN, Associated Press | News | Comments

Far from the Ebola hot zone, the sewing and gluing machines at a factory in China have been whirring more than usual to produce crucial yellow suits that protect the front-line medics more than 11,000 kilometers (7,000 miles) away in West Africa.

Beijing Wants APEC to Push Chinese Trade Pact

November 6, 2014 8:19 am | by JOE McDONALD, AP Business Writer | News | Comments

China plans to use a meeting of Asia-Pacific leaders to promote a regional trade initiative at a time when progress on a rival U.S.-led trade deal has stalled, injecting a note of rivalry into an annual summit that aims for consensus.   

GVK BIO to Acquire Vanta Bioscience

November 6, 2014 8:16 am | News | Comments

GVK BIO has announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization operating out of Chennai, India.      

Ex-Union Carbide Chief Anderson Dies at 92

November 2, 2014 6:29 pm | by CURT ANDERSON, Associated Press | News | Comments

Warren M. Anderson, who headed Union Carbide Corp. when a chemical leak killed thousands of people in Bhopal, India, in 1984, has died in Florida at 92. Anderson's death was not announced by his family but was confirmed Friday by The Associated Press through public records.

New Bill in Japan Would Extend Sales Suspension of Quasi-Legal Drugs

November 2, 2014 5:28 pm | News | Comments

The ruling Liberal Democratic Party and its coalition partner have drawn up a draft amendment to the pharmaceutical affairs law that would extend the suspension of sales of quasi-legal drugs nationwide when a retailer is ordered to suspend sales of such drugs.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading